Variant report

Variant	esv33415
Chromosome Location	chr11:17532596-17549436
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr11:17545637-17545681	HepG2	liver:	n/a	n/a
2	CEBPB	chr11:17545613-17545931	HepG2	liver:	n/a	n/a
3	CEBPB	chr11:17535555-17535638	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr11:17545610-17545814	A549	lung:	n/a	n/a
5	CTCF	chr11:17537420-17537570	SK-N-SH_RA	brain:	n/a	n/a
6	CTCF	chr11:17547960-17548110	BE2_C	brain:	n/a	n/a
7	CTCF	chr11:17537560-17537710	HEK293	kidney:	n/a	n/a
8	CTCF	chr11:17549238-17550326	SK-N-SH	brain:	n/a	chr11:17549848-17549869 chr11:17549859-17549868 chr11:17549853-17549871
9	E2F4	chr11:17535552-17535739	MCF10A-Er-Src	breast:	n/a	chr11:17535684-17535695
10	EP300	chr11:17535884-17538138	SK-N-SH	brain:	n/a	chr11:17536349-17536363 chr11:17536347-17536361 chr11:17537239-17537253 chr11:17536348-17536362 chr11:17536346-17536360 chr11:17536364-17536378 chr11:17536345-17536359 chr11:17536341-17536355
11	EP300	chr11:17531430-17532976	SK-N-SH	brain:	n/a	chr11:17532600-17532614
12	EP300	chr11:17536644-17537525	SK-N-SH_RA	brain:	n/a	chr11:17537239-17537253
13	EP300	chr11:17536751-17537543	SK-N-SH_RA	brain:	n/a	chr11:17537239-17537253
14	EP300	chr11:17536073-17536406	SK-N-SH_RA	brain:	n/a	chr11:17536349-17536363 chr11:17536347-17536361 chr11:17536348-17536362 chr11:17536346-17536360 chr11:17536364-17536378 chr11:17536345-17536359 chr11:17536341-17536355
15	EP300	chr11:17536083-17536464	SK-N-SH_RA	brain:	n/a	chr11:17536349-17536363 chr11:17536347-17536361 chr11:17536348-17536362 chr11:17536346-17536360 chr11:17536364-17536378 chr11:17536345-17536359 chr11:17536341-17536355
16	EP300	chr11:17532335-17532747	SK-N-SH_RA	brain:	n/a	chr11:17532600-17532614
17	EP300	chr11:17532355-17532758	SK-N-SH_RA	brain:	n/a	chr11:17532600-17532614
18	FOS	chr11:17535451-17535794	MCF10A-Er-Src	breast:	n/a	chr11:17535615-17535623
19	FOS	chr11:17535433-17535797	MCF10A-Er-Src	breast:	n/a	chr11:17535615-17535623
20	FOS	chr11:17535633-17535717	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr11:17535475-17535779	MCF10A-Er-Src	breast:	n/a	chr11:17535615-17535623
22	GATA2	chr11:17532514-17532967	SH-SY5Y	brain:	n/a	n/a
23	GATA2	chr11:17536790-17537759	SH-SY5Y	brain:	n/a	chr11:17537186-17537196 chr11:17537186-17537195 chr11:17537188-17537198 chr11:17537188-17537195 chr11:17537511-17537521 chr11:17537181-17537202
24	GATA2	chr11:17536119-17536414	SH-SY5Y	brain:	n/a	n/a
25	GATA3	chr11:17536222-17536314	SH-SY5Y	brain:	n/a	n/a
26	GATA3	chr11:17536883-17537385	MCF-7	breast:	n/a	chr11:17537186-17537196 chr11:17537186-17537195 chr11:17537188-17537198 chr11:17537188-17537195 chr11:17537181-17537202
27	GATA3	chr11:17532269-17532794	SH-SY5Y	brain:	n/a	chr11:17532433-17532443
28	GATA3	chr11:17536782-17537550	SK-N-SH	brain:	n/a	chr11:17537186-17537196 chr11:17537186-17537195 chr11:17537188-17537198 chr11:17537188-17537195 chr11:17537511-17537521 chr11:17537181-17537202
29	GATA3	chr11:17536857-17537494	SH-SY5Y	brain:	n/a	chr11:17537186-17537196 chr11:17537186-17537195 chr11:17537188-17537198 chr11:17537188-17537195 chr11:17537181-17537202
30	GATA3	chr11:17536737-17537572	SK-N-SH	brain:	n/a	chr11:17537186-17537196 chr11:17537186-17537195 chr11:17537188-17537198 chr11:17537188-17537195 chr11:17537511-17537521 chr11:17537181-17537202
31	JUN	chr11:17539994-17540030	H1-hESC	embryonic stem cell:	n/a	n/a
32	MAFK	chr11:17545207-17545432	HepG2	liver:	n/a	chr11:17545285-17545299 chr11:17545286-17545301
33	MAFK	chr11:17545247-17545381	HepG2	liver:	n/a	chr11:17545285-17545299 chr11:17545286-17545301
34	MAZ	chr11:17539567-17539726	HepG2	liver:	n/a	n/a
35	MYC	chr11:17548860-17548947	H1-hESC	embryonic stem cell:	n/a	n/a
36	MYC	chr11:17535555-17535644	MCF10A-Er-Src	breast:	n/a	n/a
37	NR2F2	chr11:17536891-17537313	MCF-7	breast:	n/a	n/a
38	PBX3	chr11:17532290-17532806	SK-N-SH	brain:	n/a	n/a
39	PBX3	chr11:17532353-17532777	SK-N-SH	brain:	n/a	n/a
40	PBX3	chr11:17536830-17537331	SK-N-SH	brain:	n/a	n/a
41	POLR2A	chr11:17532402-17532647	SK-N-SH	brain:	n/a	n/a
42	POLR2A	chr11:17533114-17533188	GM12878	blood:	n/a	n/a
43	POLR2A	chr11:17545594-17545599	GM12878	blood:	n/a	n/a
44	POLR2A	chr11:17536876-17537294	SK-N-SH	brain:	n/a	n/a
45	POLR2A	chr11:17532340-17532702	SK-N-SH	brain:	n/a	n/a
46	POLR2A	chr11:17545632-17545669	GM12878	blood:	n/a	n/a
47	RAD21	chr11:17549419-17550971	SK-N-SH	brain:	n/a	chr11:17549875-17549889 chr11:17550793-17550805 chr11:17549851-17549870
48	RCOR1	chr11:17533706-17533971	K562	blood:	n/a	n/a
49	REST	chr11:17537164-17537613	SK-N-SH	brain:	n/a	n/a
50	SMC3	chr11:17549436-17550327	SK-N-SH	brain:	n/a	chr11:17549855-17549869

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:17540282-17540332	AG04449	skin:	fetal
2	chr11:17540282-17540332	HL-60	blood:	n/a
3	chr11:17540282-17540332	HCT-116	colon:	n/a
4	chr11:17540282-17540332	SAEC	small airway:	n/a
5	chr11:17540282-17540332	SK-N-MC	brain:	n/a
6	chr11:17540282-17540332	AG04450	lung:	fetal
7	chr11:17540282-17540332	A549	lung:	n/a
8	chr11:17540282-17540332	IMR90	lung:	fetal
9	chr11:17540282-17540332	PrEC	prostate:	n/a
10	chr11:17540282-17540332	HNPCEpiC	eye:	n/a
11	chr11:17540282-17540332	AoSMC	blood vessel:	n/a
12	chr11:17540282-17540332	CMK	blood:	n/a
13	chr11:17540282-17540332	Caco-2	colon:	n/a
14	chr11:17540282-17540332	NHDF-neo	bronchial:	n/a
15	chr11:17540282-17540332	NH-A	brain:	n/a
16	chr11:17540282-17540332	HAEpiC	amniotic membrane:	n/a
17	chr11:17540282-17540332	HIPEpiC	eye:	n/a
18	chr11:17540282-17540332	HEEpiC	esophagus:	n/a
19	chr11:17540282-17540332	LNCaP	prostate:	n/a
20	chr11:17540282-17540332	NB4	blood:	n/a
21	chr11:17540282-17540332	K562	blood:	n/a
22	chr11:17540282-17540332	BE2_C	brain:	n/a
23	chr11:17540282-17540332	U87	brain:	n/a
24	chr11:17540282-17540332	GM12892	blood:	n/a
25	chr11:17540282-17540332	H1-hESC	embryonic stem cell:	embryo
26	chr11:17540282-17540332	MCF-7	breast:	n/a
27	chr11:17540282-17540332	GM19239	blood:	n/a
28	chr11:17540282-17540332	HCPEpiC	choroid plexus:	n/a
29	chr11:17540282-17540332	SK-N-SH	brain:	n/a
30	chr11:17540282-17540332	Hepatocyte	liver:	n/a
31	chr11:17540282-17540332	HRCEpiC	kidney:	n/a
32	chr11:17540282-17540332	PANC-1	pancreas:	n/a
33	chr11:17540282-17540332	AG10803	skin:	n/a
34	chr11:17540282-17540332	HRPEpiC	eye:	n/a
35	chr11:17540282-17540332	ovcar-3	ovarian:	n/a
36	chr11:17540282-17540332	BJ	skin:	n/a
37	chr11:17540282-17540332	GM12891	blood:	n/a
38	chr11:17540282-17540332	NHBE	bronchial:	n/a
39	chr11:17540282-17540332	SKMC	muscle:	n/a
40	chr11:17540282-17540332	T-47D	breast:	n/a
41	chr11:17540282-17540332	GM06990	blood:	n/a
42	chr11:17540282-17540332	AG09319	gingival:	n/a
43	chr11:17540282-17540332	NT2-D1	testis:	n/a
44	chr11:17540282-17540332	SK-N-SH_RA	brain:	n/a
45	chr11:17540282-17540332	ProgFib	skin:	n/a
46	chr11:17540282-17540332	Hela-S3	cervix:	n/a
47	chr11:17540282-17540332	HCM	heart:	n/a
48	chr11:17540282-17540332	HPAEpiC	pulmonary alveolar:	n/a
49	chr11:17540282-17540332	ECC-1	luminal epithelium:	n/a
50	chr11:17540282-17540332	HEK293	kidney:	embryo

No.	Distal block	Cell Line	Cell type
1	chr11:17408865..17412169-chr11:17547784..17549963,3	K562	blood:
2	chr11:17375893..17376701-chr11:17549376..17550298,3	MCF-7	breast:
3	chr11:17405141..17406113-chr11:17549390..17550226,4	K562	blood:
4	chr11:17536038..17537815-chr11:17542509..17544557,2	K562	blood:
5	chr11:17537309..17539675-chr11:17540315..17542082,2	K562	blood:
6	chr11:17538690..17542408-chr11:17546927..17550590,3	MCF-7	breast:
7	chr11:17538690..17542408-chr11:17546927..17550590,3	MCF-7	breast:
8	chr11:17404201..17406453-chr11:17548482..17550709,2	K562	blood:
9	chr11:17529263..17531115-chr11:17548910..17550754,2	K562	blood:
10	chr11:17251345..17252271-chr11:17549390..17549954,2	K562	blood:
11	chr11:17401047..17402845-chr11:17547923..17549749,2	MCF-7	breast:
12	chr11:17408129..17408789-chr11:17549376..17550314,3	K562	blood:
13	chr11:17405170..17406511-chr11:17549006..17550272,4	MCF-7	breast:

Variant related genes	Relation type
USH1C	TF binding region
USH1C	CpG island
ENSG00000260196	chromatin interactions
ENSG00000187486	chromatin interactions
ENSG00000006611	chromatin interactions

Extended variants
information (count: 793 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1076311	chr11:17532597-17532598	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs542254167	chr11:17532627-17532628	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs193289923	chr11:17532666-17532667	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs115298088	chr11:17532768-17532769	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs149862500	chr11:17532775-17532776	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs532978322	chr11:17532776-17532777	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs145811782	chr11:17532802-17532803	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs75185877	chr11:17532816-17532817	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs537392100	chr11:17532817-17532818	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs112650941	chr11:17532821-17532822	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs555370195	chr11:17532865-17532866	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs372302513	chr11:17532885-17532886	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs375728508	chr11:17532886-17532887	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs369223222	chr11:17532887-17532888	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs534492370	chr11:17532888-17532889	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs397827104	chr11:17532894-17532895	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs185481707	chr11:17532900-17532901	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs553871906	chr11:17532942-17532943	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs541781847	chr11:17533001-17533002	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs545888334	chr11:17533004-17533005	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs7117483	chr11:17533013-17533014	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs558173727	chr11:17533017-17533018	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs576358562	chr11:17533057-17533058	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs376702830	chr11:17533174-17533175	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs544126414	chr11:17533178-17533179	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs367844106	chr11:17533225-17533226	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs530850947	chr11:17533240-17533241	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs190530000	chr11:17533246-17533247	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs112879626	chr11:17533301-17533302	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs181657109	chr11:17533388-17533389	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs2190453	chr11:17533397-17533398	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs201083077	chr11:17533407-17533408	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs35430379	chr11:17533416-17533417	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs374822823	chr11:17533424-17533425	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs369186762	chr11:17533432-17533433	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs372926351	chr11:17533440-17533441	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs376038772	chr11:17533462-17533463	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs138996642	chr11:17533463-17533464	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs141564204	chr11:17533476-17533477	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs143683502	chr11:17533479-17533480	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs148115969	chr11:17533499-17533500	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs141729602	chr11:17533500-17533501	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs185939122	chr11:17533506-17533507	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs150152682	chr11:17533523-17533524	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs138746314	chr11:17533539-17533540	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs34691468	chr11:17533551-17533552	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs200949150	chr11:17533589-17533590	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs369670431	chr11:17533606-17533607	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs2190454	chr11:17533635-17533636	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs371208963	chr11:17533650-17533651	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Lung adenocarcinoma	17086460	CNVD
Urothelial cell carcinoma	18451213	CNVD
Lung cancer	17086460	CNVD
Uterine serous papillary cancer	19536090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:178 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:17516800-17553000	Weak transcription	Stomach Mucosa	stomach
2	chr11:17525400-17533600	Enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr11:17526200-17539400	Weak transcription	Pancreas	Pancrea
4	chr11:17526600-17536600	Weak transcription	Brain Substantia Nigra	brain
5	chr11:17526600-17537200	Weak transcription	Brain Cingulate Gyrus	brain
6	chr11:17527600-17549200	Strong transcription	Duodenum Mucosa	Duodenum
7	chr11:17528800-17544000	Weak transcription	Gastric	stomach
8	chr11:17529800-17548600	Strong transcription	Rectal Mucosa Donor 29	rectum
9	chr11:17530200-17533200	Weak transcription	Left Ventricle	heart
10	chr11:17530600-17533200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr11:17530600-17536600	Weak transcription	Colon Smooth Muscle	Colon
12	chr11:17530800-17532800	Weak transcription	Sigmoid Colon	Sigmoid Colon
13	chr11:17530800-17533000	Weak transcription	Psoas Muscle	Psoas
14	chr11:17530800-17539800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
15	chr11:17531200-17536000	Strong transcription	Rectal Mucosa Donor 31	rectum
16	chr11:17531600-17547200	Strong transcription	Fetal Intestine Large	intestine
17	chr11:17531800-17552400	Weak transcription	Pancreatic Islets	Pancreatic Islet
18	chr11:17532200-17533200	Weak transcription	Colonic Mucosa	Colon
19	chr11:17532200-17547200	Strong transcription	Fetal Intestine Small	intestine
20	chr11:17532400-17532800	Weak transcription	Spleen	Spleen
21	chr11:17532800-17533600	Enhancers	Spleen	Spleen
22	chr11:17532800-17534600	Strong transcription	Sigmoid Colon	Sigmoid Colon
23	chr11:17533000-17533400	Enhancers	Psoas Muscle	Psoas
24	chr11:17533200-17533400	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr11:17533200-17533400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
26	chr11:17533200-17533400	Enhancers	Skeletal Muscle Female	skeletal muscle
27	chr11:17533200-17533600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
28	chr11:17533200-17533600	Strong transcription	Colonic Mucosa	Colon
29	chr11:17533200-17533800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr11:17533200-17533800	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr11:17533400-17533800	Enhancers	Fetal Muscle Trunk	muscle
32	chr11:17533400-17539400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr11:17533600-17533800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr11:17533600-17537400	Weak transcription	Spleen	Spleen
35	chr11:17533600-17537600	Weak transcription	Colonic Mucosa	Colon
36	chr11:17533600-17541800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
37	chr11:17533800-17534600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr11:17533800-17539400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr11:17534000-17534200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
40	chr11:17534200-17534400	Enhancers	Brain Angular Gyrus	brain
41	chr11:17534400-17536200	Weak transcription	Brain Angular Gyrus	brain
42	chr11:17534600-17534800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr11:17534600-17535000	Weak transcription	Sigmoid Colon	Sigmoid Colon
44	chr11:17534800-17535000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
45	chr11:17534800-17535600	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr11:17535000-17535200	Strong transcription	Sigmoid Colon	Sigmoid Colon
47	chr11:17535000-17535400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr11:17535000-17538400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr11:17535200-17535600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr11:17535200-17537400	Weak transcription	Sigmoid Colon	Sigmoid Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links